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Abstract
The sympathetic-adrenal system is rapidly activated in response to sepsis or hemorrhagic shock, resulting in an increase in
circulating levels of catecholamines. Although it has been shown that the occurrence of hepatocellular dysfunction under
such conditions is associated with an early and sustained increase in plasma norepinephrine (NE), it remains unknown
whether the increased NE per se plays any role in producing hepatocellular dysfunction. To study this, exogenous NE was
administered, by implantation of a peritoneal mini-osmotic pump (consistently releasing NE), to produce a plasma level of
NE similar to that observed after sepsis or hemorrhage. At 24 h after the pump implantation, cardiac output was determined
by dye dilution technique and hepatocellular function [i.e., the maximal velocity (Vmax) and the efficiency of the transport
(Km) of in vivo indocyanine green clearance) was assessed without blood sampling. In addition, tissue perfusion in various
organs was determined using laser Doppler flowmetry. Plasma levels of interleukin-6 were measured by bioassay and liver
enzymes were assayed enzymatically. The results indicate that sustained (24 h) elevation of plasma levels of NE caused a
decrease in cardiac output and microvascular blood flow in the liver, spleen, and small intestine. In addition, the increase in
plasma NE produced significant depression in hepatocellular function as evidenced by reduced Vmax and Km. This was
associated with elevated plasma levels of liver enzymes, indicating hepatocyte injury. In addition, plasma levels of
interleukin-6 increased significantly. These findings suggest that sustained elevated levels of NE, observed after sepsis or
hemorrhagic shock, may play an important role in producing hepatocellular dysfunction and altered hepatocyte
integrity. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In spite of aggressive £uid resuscitation carried out
in the emergency room, a large number of trauma
victims subsequently die of sepsis, septic shock and
multiple organ failure [1]. Because of the liver’s cen-
tral role in metabolism and nonspeci¢c host defense
mechanism, it appears to be a key organ in the man-
ifestation of cell and organ dysfunction and failure
following various adverse circulatory conditions such
as polymicrobial sepsis or hemorrhagic shock [2^4].
Our previous studies have demonstrated that hepa-
tocellular dysfunction occurs early and persists for a
prolonged period of time following the onset of hem-
orrhagic shock [5] as well as sepsis [6,7]. In view of
this, it is essential that we understand the pathophys-
iological alterations which occur in the liver follow-
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ing trauma-hemorrhage, so that speci¢c therapeutic
approaches can be developed in order to prevent sus-
ceptibility to sepsis and to improve the survival rate
of trauma victims.
One of the earliest responses to sepsis or hemor-
rhage is sympathetic-adrenal activation, resulting in
an increase in circulating levels of catecholamines
[8,9]. Following adverse circulatory conditions such
as sepsis or hemorrhage, the internal environment in
which the sympathetic-adrenal activation is occurring
is di¡erent from the normal state. Since the sympa-
thetic-adrenal activation that occurs following hem-
orrhage is acting on a smaller blood volume, it may
actually be detrimental since it may enhance the
amount of hypoxia in the visceral organs, leading
to cellular dysfunction. Norepinephrine (NE) has
profound microvascular e¡ects. It causes constriction
of resistance blood vessels such as small arteries and
arterioles in the visceral organs via the stimulation of
K-adrenoceptors, thereby decreasing the blood £ow
to those organs. Thus, the prolonged noradrenergic
stimulation, seen following sepsis or hemorrhage,
may have deleterious e¡ects on cell and organ func-
tions. In this regard, we hypothesized that NE plays
an important role in the development of hepatocel-
lular dysfunction after sepsis or hemorrhage. There-
fore, the objective of this study was to determine
whether or not sustained elevation of plasma NE,
at a level similar to that seen during sepsis or follow-
ing hemorrhage, causes alterations in hepatocellu-
lar function as well as various hemodynamic param-
eters.
2. Materials and methods
The experiments described here were performed in
adherence to the National Institutes of Health guide-
lines for the use of experimental animals. This proj-
ect was approved by the Institutional Animal Care
and Use Committee of Rhode Island Hospital (Prov-
idence, RI).
2.1. Continuous administration of NE
NE (bitartrate salt, Sigma, St. Louis, MO) was
administered using an Alzet osmotic pump (model
2ML1, Alza, Palo Alto, CA) implanted in the peri-
toneal cavity with a rate of infusion of 10 Wl/h. The
pump was ¢lled with 6 Wg/Wl solution of NE dis-
solved in normal saline, which resulted in an infusion
rate of 1 Wg/min. In control animals, the pump was
¢lled with normal saline only. Male Sprague^Dawley
rats (275^325 g) were anesthetized with methoxy£ur-
ane and a 2-cm midline laparotomy was performed
thereafter. The pump was implanted in the peritoneal
cavity, following which the abdominal incision was
closed in two layers. After recovery from anesthesia,
the rats were returned to their cages and given food
and water ad libitum for 8 h. Sixteen hours prior to
sample collection the animals were fasted, but water
was continued ad libitum. Twenty-four hours follow-
ing pump implantation, the rats were anesthetized
again with methoxy£urane and various hemodynam-
ic parameters, hepatocellular function, and microcir-
culatory blood £ow were determined as described
below. At the end of the experiment, changes in
body weight were measured. Blood was withdrawn
via a femoral arterial catheter for the measurement
of plasma catecholamines, liver transaminases, inter-
leukin-6 (IL-6), and tumor necrosis factor-K (TNF-
K). Plasma was immediately separated by centrifuga-
tion, divided into aliquots, and stored at 370‡C until
assayed.
2.2. Catecholamine assay
Plasma levels of catecholamines (NE, epinephrine,
and dopamine) were determined using a 3H radio-
enzymatic assay with a commercially available kit
(CAT-A-KIT, Amersham, Arlington Heights, IL),
as previously described by us [9]. Brie£y, arterial
blood samples (V0.5 ml) were collected and plasma
was separated immediately. Catechol-O-methyltrans-
ferase was used to catalyze the transferral of a
[3H]methyl group from S-[3H]adenosyl-L-methionine
to a hydroxyl group on the various catecholamines.
The products of the methylation of epinephrine, NE,
and dopamine were [3H]metanephrine, [3H]nor-
metanephrine, and [3H]methoxytyramine, respec-
tively. These tritiated products were extracted from
the inorganic phase by quick-freezing in a dry-ice
bath and then separated using thin layer chromatog-
raphy. [3H]Methoxytyramine was measured immedi-
ately following separation, while [3H]metanephrine
and [3H]normetanephrine were converted to
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[3H]vanillin prior to measurement of radioactivity.
The radioactivity was then compared to that of the
standard provided in the kit and used to determine
the amount of catecholamines present.
2.3. Measurement of various hemodynamic
parameters
Mean arterial pressure (MAP) and heart rate (HR)
were measured, via the left femoral artery, by a
strain gauge pressure transducer (model P23XL; Vig-
go-Spectramed, Oxnard, CA) coupled to a polygraph
(model 7D, Grass Instruments, Quincy, MA). Car-
diac output (CO) was determined using an indocya-
nine green (ICG) dilution technique (a 2.4-French
¢ber-optic catheter and an in vivo hemore£ectome-
ter), as previously described by us [10]. Stroke vol-
ume (SV) was calculated by CO divided by HR and
total peripheral resistance (TPR) was calculated by
MAP divided by CO.
2.4. Microvascular blood £ow (MBF) assessment
Determination of MBF on the surface of the liver,
kidney, spleen, and small intestine was performed
using laser Doppler £owmetry, as previously re-
ported by us [11]. Brie£y, a 5-cm abdominal incision
was performed under methoxy£urane anesthesia and
a laser Doppler blood perfusion monitor (Laser£o,
Model BPM 403A, TSI, St. Paul, MN) with a needle
£ow probe was used. The probe was placed on the
surface of tested organs, and three measurements of
each organ were averaged. Laser Doppler £ow is an
accurate assessment of tissue perfusion since studies
have demonstrated that there is a good linear corre-
lation between laser Doppler £ow and organ blood
£ow measured by other techniques such as radio-
active microspheres and indicator clearance [6,12^
14]. The measured laser Doppler £ow was an average
of three random measurements on the surface of
each organ and expressed as microvascular red
blood cell £ux in V1 mm3 on the organ surface.
This technique has been extensively utilized in our
laboratory [6,7,15^19]. Although this is a reliable
technique for determining the alterations of organ
surface perfusion, the manufacturer-suggested £ow
unit should be considered as arbitrary rather than
absolute.
2.5. Hepatocellular function assessment
Hepatocellular function, de¢ned as the maximal
velocity (Vmax) and the transport e⁄ciency (Km) of
ICG clearance [5,20], was assessed by using an in
vivo ICG clearance technique, as previously de-
scribed by us [5]. Brie£y, the left carotid artery was
isolated under methoxy£urane anesthesia and a 2.4-
French ¢ber-optic catheter (Hospex Fiber-optics,
Chestnut Hill, MA) was inserted to the level of the
aortic arch through the carotid artery for continuous
measurement of ICG concentration using an in vivo
hemore£ectometer (Hospex Fiber-optics). The right
jugular vein was cannulated with PE-50 tubing.
Three separate doses (0.167, 0.333, and 0.833 mg/
kg body weight in 0.05 ml solution each) of ICG
(Cardio-Green, Becton Dickinson, MD) were then
administered via the right jugular catheter to the lev-
el of the right atrium for the measurement of hepa-
tocellular function. The concentration of ICG was
recorded every second for 5 min using a computer-
assisted data acquisition program (Asystant+, Asyst
Software, Rochester, NY). As previously described
[5], an ‘e’ raised to a second-order polynomial was
employed to determine the relationship between ICG
concentration and time. The calculation of Vmax and
Km was performed according to our previous publi-
cation [5].
2.6. Measurement of plasma transaminases
Plasma levels of aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) were deter-
mined as a measure of hepatocellular damage. The
plasma activities of AST and ALT were assayed en-
zymatically with commercially available kits (Sigma).
2.7. Determination of plasma IL-6 and TNF
Blood samples (V1 ml/rat) were collected and
plasma was separated immediately. Samples were ¢l-
tered through a 0.22-Wm ¢lter. The samples were
then diluted starting at 1:10 (plasma:media) in
RPMI-1640 (Gibco-BRL, Grand Island, NY) con-
taining 10% heat-inactivated fetal calf serum (Biolo-
gos, Napierville, IL) and by twofold steps thereafter.
IL-6 activity in plasma samples was determined as
previously described by Hu«ltner et al. [21] utilizing
BBADIS 61994 24-11-00
P. Wang et al. / Biochimica et Biophysica Acta 1535 (2000) 36^4438
the IL-6 dependent 7TD1 B-cell hybridoma. Sample
dilutions used in the above assays were tested in
duplicate. The relative unit value of plasma activity
per milliliter for IL-6 was determined by a compar-
ison of the curves produced from dilution of the ex-
perimental plasma to those generated by dilution of
a recombinant human IL-6 standard (200 U/ml; Am-
gen, Thousand Oaks, CA). It should be pointed out
that the above assays have been shown to react in a
speci¢c fashion to IL-6 [21]. TNF activity was deter-
mined by its cytotoxic e¡ect on the ¢brosarcoma cell
line WEHI 164 subclone 13 [22].
2.8. Statistical analysis
Results are presented as means þ S.E.M. Unpaired
Student’s t-test was used and the di¡erences were
considered signi¢cant at P90.05.
3. Results
3.1. Plasma levels of catecholamines
The infusion rate of NE used in this study (1 Wg/
min) increased the plasma levels of NE by more than
13-fold (from an average of 212 to 3123 pg/ml) at 24
h after the implantation of the osmotic pump con-
taining NE (Fig. 1). In contrast, plasma levels of
dopamine or epinephrine did not increase after 24
h infusion of NE (Fig. 1). It should be noted that
plasma NE levels of 3123 pg/ml are similar to those
observed following hemorrhage [23] or during sepsis
[9].
3.2. Alterations in various hemodynamic parameters
As shown in Table 1, MAP decreased by 13%
(P6 0.05) at 24 h after continuous infusion of NE
with no change in HR.CO and SV decreased by ap-
proximately 32% (P6 0.05) at 24 h after the pump
implantation. In contrast, TPR increased signi¢-
cantly under such conditions (Table 1). Body weight
loss increased from an average of 0.4 to 8.3%
(P6 0.05) after 24 h infusion of NE (Table 1). The
possible causes for the decrease in body weight after
prolonged infusion of NE are due to loss of £uid, as
evidenced by the increase in systemic hematocrit
from 46 þ 1% to 51 þ 1% (P6 0.05), and the elevated
level of basal metabolism of the animals induced by
Fig. 1. Alterations in plasma levels of catecholamines (i.e., dop-
amine, epinephrine, and norepinephrine) at 24 h after the im-
plantation in the mini-osmotic pump ¢lled with either normal
saline or norepinephrine (NE) solution. Data are expressed as
mean þ S.E.M. (n = 6/group), and compared by unpaired Stu-
dent’s t-test : *P6 0.05 versus saline group.
Table 1
Alterations in various systemic hemodynamic parameters at 24 h after implantation of the mini-osmotic pump containing norepinephr-
ine
Saline Norepinephrine
MAP (mmHg) 109.7 þ 3.6 95.7 þ 4.7*
HR (beats/min) 411 þ 14 410 þ 6
CO (ml/min per 100 g body weight) 33.1 þ 1.3 22.5 þ 0.8*
SV (Wl/beat per 100 g body weight) 80.5 þ 3.7 55.0 þ 2.1*
TPR (mmHg/ml per min) 1.20 þ 0.03 1.63 þ 0.13*
Body weight loss (%) 0.4 þ 1.3 8.3 þ 0.3*
MAP, mean arterial pressure; HR, heart rate; CO, cardiac output; SV, stroke volume; TPR, total peripheral resistance. Values are
presented as mean þ S.E.M. (n = 6^7/group), and compared by unpaired Student’s t-test: *P6 0.05 versus saline group.
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NE. It is also possible that the NE-infused animals
reduced their food and water intake. In addition, NE
infusion caused a signi¢cant reduction in microvas-
cular blood £ow in the liver (by 48%), spleen (by
51%), and small intestine (by 25%) (P6 0.05) (Fig.
2). Although renal MBF decreased by 18% at 24 h
after the pump implantation, such a decrease was not
statistically signi¢cant.
3.3. Alterations in hepatocellular function and plasma
liver enzymes
The Vmax of the in vivo ICG clearance by the liver
decreased by 60% (P6 0.05) at 24 h after the implan-
tation of NE pumps (Fig. 3A). Similarly, Km values
of ICG uptake by hepatocytes was only 26% of the
sham level in NE-infused animals (P6 0.05, Fig. 3B).
Moreover, NE infusion for 24 h increased the circu-
lating levels of AST by 732% (P6 0.05) and of ALT
by 517% (P6 0.05), respectively (Fig. 4).
3.4. Alteration in circulating levels of IL-6 and TNF
Plasma levels of IL-6 increased from 1.5 þ 1.0 to
45.2 þ 19.6 U/ml (P6 0.05, n = 6/group) after 24 h
infusion of NE. Although the circulating levels of
TNF increased from 2.2 þ 1.8 to 5.7 þ 4.7 U/ml
Fig. 2. Alterations in microvascular blood £ow (MBF) in the
liver, kidneys, spleen, and small intestine at 24 h after the im-
plantation in the mini-osmotic pump ¢lled with either normal
saline or norepinephrine (NE) solution. Data are expressed as
mean þ S.E.M. (n = 6/group), and compared by unpaired Stu-
dent’s t-test: *P6 0.05 versus saline group.
Fig. 3. Alterations in the maximal velocity of indocyanine green
clearance (Vmax, A) and the e⁄ciency of the active transport
(Km, B) at 24 h after the implantation in the mini-osmotic
pump ¢lled with either normal saline or norepinephrine solu-
tion. Data are expressed as mean þ S.E.M. (n = 6/group), and
compared by unpaired Student’s t-test : *P6 0.05 versus the sa-
line group.
Fig. 4. Alterations in the circulating levels of aspartate amino-
transferase (AST) and alanine aminotransferase (ALT) at 24 h
after the implantation in the mini-osmotic pump ¢lled with ei-
ther normal saline or norepinephrine (NE) solution. Data are
expressed as mean þ S.E.M. (n = 6/group), and compared by un-
paired Student’s t-test : *P6 0.05 versus the normal saline
group.
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(n = 6/group) after 24 h infusion of NE, such an in-
crease was not statistically signi¢cant.
4. Discussion
Catecholamines are released after sepsis or hemor-
rhage due to neural re£exes involving the sympa-
thetic nervous system. Under normal conditions,
the a¡erent information associated with the realiza-
tion of danger, £uid loss, tissue damage, and infec-
tion leads to an increase in the activity of the sym-
pathetic preganglionic nerve ¢bers. This increase in
sympathetic nervous system activity causes release of
NE from postganglionic neurons. Elevations in plas-
ma levels of NE have been observed in a variety of
conditions involving sepsis or hypoperfusion [8,9,23^
25]. It has been observed that circulating levels of
NE are higher in patients that are critically injured
as compared to those that are moderately injured
[24,25]. Furthermore, in patients with multi-system
trauma including head injury, plasma NE levels
were highly correlated with patient mortality [8].
Similarly, plasma levels of NE increase early after
the onset of sepsis and are sustained even at the
late stage of sepsis [9]. The persisted elevation in
levels of NE following sepsis or hemorrhage may
have a variety of deleterious e¡ects on organ func-
tions. The present study was, therefore, conducted to
determine whether a sustained elevation of circulat-
ing levels of NE in the absence of blood loss or sepsis
alters hepatocellular function and cardiovascular re-
sponses.
Our results indicate that the implantation of the
osmotic pump containing NE for 24 h produced
plasma NE levels of approximately 3000 pg/ml.
This level of plasma NE is similar to that observed
following polymicrobial sepsis [9] or hemorrhage and
resuscitation [23], as previously reported from our
laboratory. The increase in plasma NE produced a
signi¢cant depression in hepatocellular function as
evidenced by the reduced Vmax and Km of in vivo
ICG clearance. Moreover, circulating levels of liver
enzymes AST and ALT increased signi¢cantly at 24
h after the pump implantation, indicating hepatocyte
injury. Proin£ammatory cytokine IL-6 was also
found to be signi¢cantly increased after NE infusion.
Thus, the sustained high level of NE plays an impor-
tant role in altering hepatocellular function as well as
hepatocyte integrity. The e¡ect of the prolonged in-
fusion of NE on myocardial function (i.e., decreased
cardiac output, decreased blood pressure in spite of
elevated total peripheral resistance with no change in
heart rate) appears to be due to a direct e¡ect of NE
on the myocardium (possibly via upregulation of
TNF-K), prolonged increase in afterload, or the com-
bination of both. To assess whether infusion of NE
for a shorter period of time alters general hemody-
namics, we infused NE via the portal vein and mean
arterial pressure was monitored every 5 min for 2 h.
Our preliminary results indicate that there was no
signi¢cant alterations in mean arterial pressure over
the course of NE infusion. This would suggest that
exposure to NE longer than 2 h is required to pro-
duce the cardiovascular alterations observed in the
current study. It is therefore postulated that the ele-
vated plasma levels of NE, observed following poly-
microbial sepsis [9] or hemorrhage and resuscitation
[23], may be responsible for producing hepatocellular
dysfunction under those conditions [3,5,6,26].
ICG clearance has been demonstrated to be an
extremely sensitive and early indication of hepatocel-
lular abnormality during sepsis [6,27,28] and follow-
ing other adverse circulatory conditions such as trau-
ma and hemorrhagic shock [5,29]. ICG is cleared
exclusively by the liver through an energy-dependent
membrane transport mechanism and is nontoxic at
low doses [30,31]. Paumgartner et al. [31] suggested
that the capacity of liver to remove ICG has a max-
imal limit. Their studies also indicated that the clas-
sic Michaelis^Menten kinetics (with Lineweaver^
Burk plot) could be applied to the initial ICG uptake
in the rat and human livers. An in vivo ICG clear-
ance technique for assessing active hepatocellular
function in the rat without the need for blood sam-
pling has been developed by us [5,6]. Brie£y, three
di¡erent doses of ICG (0.167, 0.333, and 0.833 mg/kg
body weight) were administered intravenously, and
ICG concentration was measured in vivo with a ¢-
ber-optic catheter and an in vivo hemore£ectometer.
The initial velocity of the clearance of ICG was cal-
culated according to the mathematical constant e
raised to a second-order polynomial ([ICG] =
eabtct
2
). Vmax of ICG clearance (the number of
functional ICG receptors/carriers on hepatocytes)
and kinetic constant (Km : the e⁄ciency of the active
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transport processes) were determined from the Line-
weaver^Burk plot [5]. Thus, Vmax and Km of ICG
clearance represent di¡erent aspects of active hepa-
tocellular function. The polypeptide responsible for
ICG transport in hepatocytes (i.e., organic anion-
transporting polypeptide, OATP) has recently been
cloned and functionally characterized [32,33]. The
functional examination of OATP revealed that it is
a novel hepatocellular organic anion uptake system
that is able to mediate Na-independent transport of
monovalent and divalent cholephilic organic anions
including ICG [33]. Measurement of hepatocellular
function by the in vivo ICG clearance technique is
particularly useful since it does not require blood or
tissue sampling. Moreover, early studies using this
technique revealed that ICG clearance decreased at
an early stage of sepsis (5 h after the onset of sepsis)
prior to elevations in serum enzyme levels (i.e., ALT,
AST) [27]. Because elevated serum liver enzymes do
not re£ect early hepatocellular dysfunction but rather
hepatocyte damage, ICG clearance is considered to
be a sensitive technique for assessing the early and
subtle alterations in hepatocellular function follow-
ing various adverse circulatory conditions. However,
it should be pointed out that ICG clearance only
measures the alterations of substance clearance of
the hepatocyte functions.
Norepinephrine has been shown to decrease the
blood £ow through the liver, thus depressing oxygen
delivery by increasing hepatic arteriolar and venous
resistance via stimulation of vascular K-adrenergic
receptors [34,35]. Although NE is known to moder-
ately increase cardiac contractility, it also causes pro-
nounced global vasoconstriction and no vasodilation.
Vasoconstriction to the visceral organs is detrimental
since the reduction in visceral organ perfusion can
cause regional hypoxia, thereby producing altera-
tions in cellular function and initiating in£ammatory
responses. This notion is supported by the present
¢nding that microvascular blood £ow was signi¢-
cantly reduced in the liver, gut and spleen following
intraperitoneal administration of NE for 24 h. It is,
therefore, possible that NE-induced hepatocellular
dysfunction and hepatocyte injury is secondary to
the reduced hepatic perfusion and depressed cardio-
vascular function caused by prolonged infusion of
this agent. In contrast to the e¡ect of prolonged in-
fusion of NE on the hepatocyte, our recent studies
have indicated that the gut-derived NE appears to
play an important role in depressing hepatocellular
function during the early stage of sepsis [36,37]. In
addition, our results demonstrate that portal levels of
NE were signi¢cantly higher than systemic levels
after 2 h after the onset of sepsis (i.e., cecal ligation
and puncture) and prior enterectomy reduced NE
levels in septic animals. Thus, the gut appears to be
the major source of NE release during sepsis. Our
recent results also indicate that enterectomy prior
to sepsis attenuated hepatocellular dysfunction dur-
ing the early stage of sepsis. Moreover, perfusion of
the isolated liver with 20 nM NE (similar to that
observed during sepsis) over 60 min signi¢cantly re-
duced ICG clearance capacity [37]. Furthermore, our
preliminary results show that administration of NE
in normal animals via the portal vein caused hepa-
tocellular dysfunction. Thus, the increased gut-de-
rived NE plays a signi¢cant role in producing hepa-
tocellular dysfunction during sepsis. Although the
precise mechanism responsible for the e¡ects of NE
on hepatocellular function during early sepsis re-
mains to be further de¢ned, it appears that the in-
creased gut-derived NE during early sepsis upregu-
lates TNF-K production in Kup¡er cells through an
K2-adrenoceptor pathway and is responsible for pro-
ducing hepatocellular depression [36]. However, the
hepatocellular dysfunction and hepatocyte damage
reported in this study may be the result of the pro-
longed reduction of hepatic perfusion and cardiac
output.
The present study shows that following chronic
infusion of NE, there was a signi¢cant increase in
the circulating levels of IL-6 without an increase in
the circulating levels of TNF. Studies have shown
that rats chronically infused with NE showed cachex-
ia and increased temperature, while those infused
with epinephrine did not exhibit these alterations
[38]. The elevation in plasma IL-6 levels following
NE infusion correlates well with the observation
that the increase in plasma IL-6 persists following
hemorrhage and during sepsis, both of which are
conditions associated with high NE levels [39,40].
Although stimulation of K2-adrenoceptors on macro-
phages by NE or other K2-adrenergic agonists in-
creases TNF production [41^43], it remains unknown
whether NE-induced upregulation of IL-6 is medi-
ated by macrophage (Kup¡er cell) K2-adrenoceptor
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stimulation by this catecholamine. Additional studies
using co-administration of NE with K2-adrenergic
antagonists such as rauwolscine are required to de-
termine whether hepatocellular dysfunction induced
by persistent elevation of NE is mediated by activa-
tion of K2-adrenoceptors. It should be noted that
continuous administration of NE into the perito-
neum for a period of 24 h may not completely mimic
the stress conditions such as polymicrobial sepsis and
hemorrhagic shock. Nonetheless, peritoneal adminis-
tration of NE was used as the ¢rst step toward fur-
ther investigation of the role of NE in producing
hepatocellular dysfunction during sepsis.
In summary, our main ¢ndings indicate that the
sustained elevation of NE produces hepatocellular
dysfunction and signi¢cant alterations in the hepato-
cellular plasma membrane integrity. Thus, the high
levels of NE play an important role in producing
hepatocellular dysfunction and in altering hepatocyte
integrity following sepsis as well as hemorrhage.
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